Literature DB >> 22580674

Amount of operative blood loss affects the long-term outcome after liver resection for hepatocellular carcinoma.

Akira Chikamoto1, Toru Beppu, Toshiro Masuda, Ryu Otao, Hirohisa Okabe, Hiromitsu Hayashi, Shinichi Sugiyama, Masayuki Watanabe, Takatoshi Ishiko, Hiroshi Takamori, Hideo Baba.   

Abstract

BACKGROUND/AIMS: Numerous prognostic factors for HCC have been reported. Few literatures have reported clinical significance of amount of intraoperative blood loss (ABL) for the outcome after surgery for HCC. The aim of this study is to analyze the significance of ABL for outcome after surgery for HCC.
METHODOLOGY: A total of 301 patients who underwent liver resection for HCC between January 1998 and June 2007 were included. Clinical and surgical characteristics were collected and prognostic factors were identified using univariate and multivariate analysis.
RESULTS: Impaired liver function (liver damage B), large tumor (>36mm), multiple tumors, existence of macroscopic vessel invasion, large ABL (=700mL) and replacement of red blood cells were identified as independent prognostic factors for overall survival (OS). For disease free survival (DFS), old age (>66), male gender, impaired liver function, large tumor, multiple tumors, existence of macroscopic vessel invasion and large ABL were extracted. Limited to the patients without blood transfusion, large ABL is associated with poor OS and DFS.
CONCLUSIONS: Large ABL could result in poor OS and DFS after liver resection of HCC in patients without blood transfusion. Surgeons have to make the best effort to reduce ABL.

Entities:  

Mesh:

Year:  2012        PMID: 22580674     DOI: 10.5754/hge09778

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  6 in total

1.  Patent foramen ovale and long-term risk of ischaemic stroke after surgery.

Authors:  Sabine Friedrich; Pauline Y Ng; Katharina Platzbecker; Sara M Burns; Valerie Banner-Goodspeed; Christian Weimar; Balachundhar Subramaniam; Timothy T Houle; Deepak L Bhatt; Matthias Eikermann
Journal:  Eur Heart J       Date:  2019-03-14       Impact factor: 29.983

2.  Impact of intraoperative blood loss on long-term survival after lung cancer resection.

Authors:  Haruhiko Nakamura; Hisashi Saji; Noriaki Kurimoto; Takuo Shinmyo; Rie Tagaya
Journal:  Ann Thorac Cardiovasc Surg       Date:  2014-02-28       Impact factor: 1.520

3.  Preoperative Neutrophil-to-Lymphocyte Ratio Plus Platelet-to-Lymphocyte Ratio Predicts the Outcomes after Curative Resection for Hepatocellular Carcinoma.

Authors:  T Kabir; M Ye; N A Mohd Noor; W Woon; S P Junnarkar; V G Shelat
Journal:  Int J Hepatol       Date:  2019-04-02

4.  Is left-sided involvement of hepatocellular carcinoma an important preoperative predictive factor of poor outcome?

Authors:  Yuhki Sakuraoka; Keiichi Kubota; Genki Tanaka; Takayuki Shimizu; Kazuma Tago; Kyung Hwa Park; Takatsugu Matsumoto; Takayuki Shiraki; Shozo Mori; Yukihiro Iso; Taku Aoki
Journal:  World J Surg Oncol       Date:  2020-12-03       Impact factor: 2.754

5.  Comparing outcomes of two vascular inflow occlusion techniques and treatment without vascular occlusion during major hepatectomy in patients with Hepatitis B-related hepatocellular carcinoma.

Authors:  Zhiping Huang; Peng Zhang; Haiqing Wang; Lunan Yan; Wentao Wang
Journal:  PLoS One       Date:  2014-09-09       Impact factor: 3.240

6.  A 5-year recurrence-free survivor with over ten colorectal liver metastases undergoing FOLFOX plus bevacizumab followed by two-stage hepatectomy.

Authors:  Yuka Tamaoki; Toru Beppu; Yasuo Sakamoto; Katsunori Imai; Hiromitsu Hayashi; Hidetoshi Nitta; Daisuke Hashimoto; Yuji Miyamoto; Yutaka Tsuruta; Akira Chikamoto; Hideo Baba
Journal:  Surg Case Rep       Date:  2015-10-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.